Fingertip Formulary launches iPad apps at AMCP annual meeting

NewsGuard 100/100 Score

Fingertip Formulary, the leading provider of access and insight into formulary data, announced the launch of their iPad applications today at the Academy of Managed Care Pharmacy (AMCP) annual meeting. Pharmaceutical reps can now access real time formulary data searchable by: state, health plan, drug class or specific drug name on their iPad.    

Fingertip Formulary covers formulary data for 1800 plans nationwide including Commercial, Medicare, Medicaid and Pharmacy Benefit Managers. Formulary data is updated on a rolling basis to provide the most accurate search results for its customers.

"The new iPad applications are the best of all worlds in terms of functionality and content," said Fingertip Formulary Senior Vice President, Sales and Development Mike Green. "A rep can be sitting in front of a physician and pull up the formulary data on their iPad that the healthcare professional needs to support their prescribing decisions."

Clients that license Fingertip Formulary Publisher can now also use their iPad to create formulary tables in real-time with their customized brand-specific templates. Tables can be created at the state, metropolitan statistical area or local level. Reps can create a formulary table in their car and have it ready to share with a physician in their office. Reps can also create a table on their iPad, send it to a printer electronically and pick up the hard copies in real time.

Pharmaceutical companies are starting to arm their field sales forces with iPads and other tablets. According to Manhattan Research's ePharma Physician report, 38 percent of ePharma Physicians have seen a pharma or biotech sales rep use an iPad or other tablet during a face-to-face meeting in a 12 month period ending in June 2011.

"We know the use of iPads by pharma reps is only going to increase over time," said Green. "We have created these new apps with that in mind."

Source:

Fingertip Formulary    

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status